Patents by Inventor Satyabrata Barik

Satyabrata Barik has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition comprising Canagliflozin, process of preparation and use thereof
    Patent number: 11857559
    Abstract: The present invention relates to a binder free stable pharmaceutical composition comprising amorphous canagliflozin or a pharmaceutically acceptable salt or a prodrug thereof, and one or more pharmaceutically acceptable excipients, wherein the said composition is devoid of canagliflozin hemihydrate, and having acceptable chemical stability, polymorphic stability & comparative dissolution and bioavailability profile to that of INVOKANA® tablets.
    Type: Grant
    Filed: November 21, 2020
    Date of Patent: January 2, 2024
    Inventors: Satyabrata Barik, Venugopala Chokkasandra Jayarama Reddy, Sivakumaran Meenakshisunderam
  • Pharmaceutical composition comprising Canagliflozin, Process of Preparation and Use Thereof
    Publication number: 20210085704
    Abstract: The present invention relates to a binder free stable pharmaceutical composition comprising amorphous canagliflozin or a pharmaceutically acceptable salt or a prodrug thereof, and one or more pharmaceutically acceptable excipients, wherein the said composition is devoid of canagliflozin hemihydrate, and having acceptable chemical stability, polymorphic stability & comparative dissolution and bioavailability profile to that of INVOKANA® tablets.
    Type: Application
    Filed: November 21, 2020
    Publication date: March 25, 2021
    Applicant: Aurobindo Pharma Ltd
    Inventors: Satyabrata BARIK, Venugopala Chokkasandra Jayarama REDDY, Sivakumaran MEENAKSHISUNDERAM
  • Pharmaceutical Composition Comprising Canagliflozin, Process of Preparation and Use Thereof
    Publication number: 20190070120
    Abstract: The present invention relates to a binder tree pharmaceutical composition comprising canagliflozin or a prodrug or a pharmaceutically acceptable salt thereof, and one or more 5 pharmaceutically acceptable excipients, wherein the said composition is devoid of canagliflozin hemihydrate, and having acceptable chemical stability, polymorphic stability & comparative dissolution and bioequivalence profile to that of INVOKANA® tablets.
    Type: Application
    Filed: March 9, 2017
    Publication date: March 7, 2019
    Applicant: Aurobindo Pharma Ltd.
    Inventors: Satyabrata Barik, Venugopala Chokkasandra Jayarama Reddy, Sivakumaran Meenakshisundaram